[Chronic pain due to degenerative and inflammatory musculoskeletal diseases in the elderly. Observational study investigating dosage, course of treatment, effectiveness and tolerability of tilidine/naloxone].
作者信息
von Renteln-Kruse W, Sarnow E, Schenkel I
机构信息
Chefarzt Medizinisch-Geriatrische Klinik, Albertinen-Haus, Sellhopsweg 18-22, D-22459 Hamburg.
出版信息
MMW Fortschr Med. 2005 Jun 23;147(25):41.
PMID:16038340
Abstract
摘要
相似文献
1
2
[Tilidine-Naloxone sustained-release tablets for chronic pain associated with musculoskeletal disease].
MMW Fortschr Med. 2006 Sep 14;148(37):45.
3
Comparative study of tilidine-naloxone and pentazocine in knee and hip osteoarthritis.
Int J Clin Pharmacol Res. 1992;12(1):1-9.
4
5
[Chronic non-malignant pain. Opioids are also suitable for long-term treatment].
MMW Fortschr Med. 2006 Apr 27;148(17):47.
6
[Experts criticize too frequent use of NSAIDs. Pain therapy with opioids: efficient and well tolerable].
MMW Fortschr Med. 2005 Nov 10;147(45):62.
7
[Comparison of the action of 2 effective analgesics. Experimental study: tramadol versus tilidine/naloxone].
Fortschr Med. 1989 Jun 10;107(17):385-9.
8
Topical review on the abuse and misuse potential of tramadol and tilidine in Germany.
Subst Abus. 2013;34(3):313-20. doi: 10.1080/08897077.2012.735216.
9
Long-term safety of Remoxy® (extended-release oxycodone) in patients with moderate to severe chronic osteoarthritis or low back pain.
Pain Med. 2011 May;12(5):755-60. doi: 10.1111/j.1526-4637.2011.01100.x. Epub 2011 Apr 11.
10
[Low-dose strong opioid (LDSO)--treatment of pain in osteoarthritis].
MMW Fortschr Med. 2008 Dec 11;150(51-52):41.
引用本文的文献
1
[Management of chronic pain using extended release tilidine : Quality of life and implication of comedication on tilidine metabolism].
Schmerz. 2017 Oct;31(5):516-523. doi: 10.1007/s00482-017-0228-8.
Zotero 插件